Antiretroviral preexposure prophylaxis for HIV prevention.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).Journal of acquired immune deficiency syndromes (1999) · 2019
   Trial
2. Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
   Trial
3. Implementation Determinants of PrEP and Behavioral Health Treatment Referral among HIV Test Counselors.AIDS and behavior · 2025
   Article
4. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women.Journal of the International AIDS Society · 2023
   Article
5. Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States.BMC infectious diseases · 2022
   Article
6. Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.AIDS and behavior · 2021
   Article
7. Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial.JMIR research protocols · 2020
   Article
8. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.Contraception · 2019
   Article
9. "I Did Not Want to Give Birth to a Child Who has HIV": Experiences Using PrEP During Pregnancy Among HIV-Uninfected Kenyan Women in HIV-Serodiscordant Couples.Journal of acquired immune deficiency syndromes (1999) · 2017
   Article
10. The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion.AIDS (London, England) · 2017
    Article
11. Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
12. Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?The Journal of infectious diseases · 2016
    Article
13. Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.Journal of acquired immune deficiency syndromes (1999) · 2015
    Review
14. HIV Prevalence Correlates with High-Risk Sexual Behavior in Ethiopia's Regions.PloS one · 2015
    Article
15. Gonadal function and reproductive health in women with human immunodeficiency virus infection.Endocrinology and metabolism clinics of North America · 2014
    Review
16. ARV-based HIV prevention for women - where we are in 2014.Journal of the International AIDS Society · 2014
    Review
17. Preferences for HIV pre-exposure prophylaxis (PrEP) information among men-who-have-sex-with-men (MSM) at community outreach settings.Journal of gay & lesbian mental health
    Article

Corrections and comments

• Comment on
  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.2012
• Comment on
  Antiretroviral preexposure prophylaxis for HIV prevention.2013

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as